Dementia knowledgeable says proof ‘wasn’t ample’ for approval
Dementia expert Dr. Jason Karlawish told CNBC he was skeptical about the Food and Drug Administration's approval of Biogen's Alzheimer's drug Aduhelm."Another study is needed to see if this drug is actually effective. Unfortunately, the…